Sylvia C. Kurz, MD, PhD

Media Releases

Internationally Acclaimed Specialist Brings Expertise in Brain Tumors and Immunotherapy to Yale’s Chênevert Family Brain Tumor Center

An esteemed neuro-oncologist, Dr. Kurz is an Associate Professor of Neurology at the Chênevert Family Brain Tumor Center at Smilow Cancer Hospital at New Haven, Connecticut. She is an internationally acclaimed neuro-oncologist whose extensive education and experience in the field position her as a leader in the treatment and research of brain tumors.

She earned both her medical degree and PhD from Ludwig-Maximilians-University in Munich, Germany. She completed neurology residency at University Hospitals Case Medical Center and an esteemed fellowship in Neuro-Oncology Fellowship Program at the Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women’s Hospital in Boston. After serving as an Assistant Professor and Interim Director of the Neuro-Oncology Program at Perlmutter Cancer Center in New York, she returned to Germany to work at the Institute for Neurology and Interdisciplinary Neuro-Oncology at the University Hospital Tübingen and Eberhard Karls University of Tübingen. 

At Yale, Dr. Kurz leverages her expertise to care for patients with brain tumors, particularly gliomas and meningiomas, and those who experience cancer- and cancer therapy-associated side effects of the nervous system. Her personalized and patient-centered approach ensures that each individual receives the best possible care tailored to their unique needs.

In addition to her clinical responsibilities, she is deeply involved in translational and clinical research, working as a principal investigator on numerous investigator-initiated, cooperative group and industry-sponsored clinical trials, including several focused on immunotherapy. She is dedicated to developing innovative treatment options for patients with progressive and therapy-resistant gliomas and intracranial meningiomas, a particularly challenging area in neuro-oncology.

Recommended Articles

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...

• Schools Join the Fight Against Lymphoma and Blood Cancers

  Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...

• Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma

  Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....

• Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission

  4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...